FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Luigi Cattel

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Procedures

Antineoplastic Combined Chemotherapy Protocols

Concepts & Ideas

Co-author Network

Publications

TOP 3
Franco Dosio; Annalisa Ferrero; Claudio Garino; Susanna Giordano; Silvia Arpicco; Luigi Cattel; Barbara Stella; Daniele Zonari; Roberto Gobetto
Ruthenium polypyridyl squalene derivative: a novel self-assembling lipophilic probe for cellular imaging.
Dario Cocito; Leonardo Lopiano; Ilaria Paolasso; Grazia Serra; Diego A Barilà; Luigi Cattel
Economic and quality of life evaluation of different modalities of immunoglobulin therapy in chronic dysimmune neuropathies.
Paola Milla; Franco Dosio; Luigi Cattel
PEGylation of proteins and liposomes: a powerful and flexible strategy to improve the drug delivery.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Luigi Cattel (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Franco Dosio; Annalisa Ferrero; Claudio Garino; Susanna Giordano; Silvia Arpicco; Luigi Cattel; Barbara Stella; Daniele Zonari; Roberto Gobetto
Ruthenium polypyridyl squalene derivative: a novel self-assembling lipophilic probe for cellular imaging.
International journal of pharmaceutics 2013;440(2):221-8.
2012: Dario Cocito; Leonardo Lopiano; Ilaria Paolasso; Grazia Serra; Diego A Barilà; Luigi Cattel
Economic and quality of life evaluation of different modalities of immunoglobulin therapy in chronic dysimmune neuropathies.
Journal of the peripheral nervous system : JPNS 2012;17(4):426-8.
2012: Paola Milla; Franco Dosio; Luigi Cattel
PEGylation of proteins and liposomes: a powerful and flexible strategy to improve the drug delivery.
Current drug metabolism 2012;13(1):105-19.
2011: Franco Dosio; Paola Brusa; Luigi Cattel
Immunotoxins and anticancer drug conjugate assemblies: the role of the linkage between components.
Toxins 2011;3(7):848-83.
2011: Federica Lince; Sara Bolognesi; Daniele L Marchisio; Barbara Stella; Franco Dosio; Antonello A Barresi; Luigi Cattel
Preparation of poly(MePEGCA-co-HDCA) nanoparticles with confined impinging jets reactor: experimental and modeling study.
Journal of pharmaceutical sciences 2011;100(6):2391-405.
2011: Franco Dosio; Barbara Stella; Silvia Arpicco; Luigi Cattel
Macromolecules as taxane delivery systems.
Expert opinion on drug delivery 2011;8(1):33-55.
2010: Franco Dosio; Paola Milla; Luigi Cattel
EC-145, a folate-targeted Vinca alkaloid conjugate for the potential treatment of folate receptor-expressing cancers.
Current opinion in investigational drugs (London, England : 2000) 2010;11(12):1424-33.
2010: Paolo Gontero; Luigi Cattel; Tonia C Paone; Paola Milla; Giovanna Berta; Chiara Fiorito; Francesco Carbone; Claudio Medana; Alessandro Tizzani
Pharmacokinetic study to optimize the intravesical administration of gemcitabine.
BJU international 2010;106(11):1652-6.
2010: Franco Dosio; L Harivardhan Reddy; Annalisa Ferrero; Barbara Stella; Luigi Cattel; Patrick Couvreur
Novel nanoassemblies composed of squalenoyl-paclitaxel derivatives: synthesis, characterization, and biological evaluation.
Bioconjugate chemistry 2010;21(7):1349-61.
2009: Franco Dosio; Silvia Arpicco; Barbara Stella; Paola Brusa; Luigi Cattel
Folate-mediated targeting of albumin conjugates of paclitaxel obtained through a heterogeneous phase system.
International journal of pharmaceutics 2009;382(1-2):117-23.
2009: Claudio Surace; Silvia Arpicco; Amélie Dufaÿ-Wojcicki; Véronique Marsaud; Céline Bouclier; Denis Clay; Luigi Cattel; Jack-Michel Renoir; Elias Fattal
Lipoplexes targeting the CD44 hyaluronic acid receptor for efficient transfection of breast cancer cells.
Molecular pharmaceutics 2009;6(4):1062-73.
2009: Paola Milla; Mario Airoldi; Günther Weber; Anne Drescher; Ulrich Jaehde; Luigi Cattel
Administration of reduced glutathione in FOLFOX4 adjuvant treatment for colorectal cancer: effect on oxaliplatin pharmacokinetics, Pt-DNA adduct formation, and neurotoxicity.
Anti-cancer drugs 2009;20(5):396-402.
2008: Caroline Norez; Matteo Pasetto; Maria Cristina Dechecchi; Erika Barison; Cristina Anselmi; Anna Tamanini; Federica Quiri; Luigi Cattel; Paolo Rizzotti; Franco Dosio; Giulio Cabrini; Marco Colombatti
Chemical conjugation of DeltaF508-CFTR corrector deoxyspergualin to transporter human serum albumin enhances its ability to rescue Cl- channel functions.
American journal of physiology. Lung cellular and molecular physiology 2008;295(2):L336-47.
2008: Mario Airoldi; Luigi Cattel; Paola Milla; Fulvia Pedani; Massimiliano Garzaro; Franco Dosio
Paclitaxel and pegylated liposomal doxorubicin in recurrent head and neck cancer: clinical and unexpected pharmacokinetic interactions.
Anticancer research 2008;28(4C):2519-27.
2007: Francesco Castelli; Maria Grazia Sarpietro; Dorotea Micieli; Barbara Stella; Flavio Rocco; Luigi Cattel
Enhancement of gemcitabine affinity for biomembranes by conjugation with squalene: differential scanning calorimetry and Langmuir-Blodgett studies using biomembrane models.
Journal of colloid and interface science 2007;316(1):43-52.
2007: Barbara Stella; Silvia Arpicco; Flavio Rocco; Véronique Marsaud; Jack-Michel Renoir; Luigi Cattel; Patrick Couvreur
Encapsulation of gemcitabine lipophilic derivatives into polycyanoacrylate nanospheres and nanocapsules.
International journal of pharmaceutics 2007;344(1-2):71-7.
2007: Francesco Castelli; Maria Grazia Sarpietro; Flavio Rocco; Maurizio Ceruti; Luigi Cattel
Interaction of lipophilic gemcitabine prodrugs with biomembrane models studied by Langmuir-Blodgett technique.
Journal of colloid and interface science 2007;313(1):363-8.
2007: Barbara Stella; Véronique Marsaud; Silvia Arpicco; Gérard Géraud; Luigi Cattel; Patrick Couvreur; Jack-Michel Renoir
Biological characterization of folic acid-conjugated poly(H2NPEGCA-co-HDCA) nanoparticles in cellular models.
Journal of drug targeting 2007;15(2):146-53.
2007: Paola Brusa; Maria Laura Immordino; Flavio Rocco; Luigi Cattel
Antitumor activity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs.
Anticancer research 2007;27(1A):195-9.
2006: Francesco Castelli; Maria Grazia Sarpietro; Maurizio Ceruti; Flavio Rocco; Luigi Cattel
Characterization of lipophilic gemcitabine prodrug-liposomal membrane interaction by differential scanning calorimetry.
Molecular pharmaceutics 2006;3(6):737-44.
2006: Patrick Couvreur; Barbara Stella; L Harivardhan Reddy; Hervé Hillaireau; Catherine Dubernet; Didier Desmaële; Sinda Lepêtre-Mouelhi; Flavio Rocco; Nathalie Dereuddre-Bosquet; Pascal Clayette; Véronique Rosilio; Véronique Marsaud; Jack-Michel Renoir; Luigi Cattel
Squalenoyl nanomedicines as potential therapeutics.
Nano letters 2006;6(11):2544-8.
2006: Mario Airoldi; Luigi Cattel; Roberto Passera; Fulvia Pedani; Laura Delprino; Caterina Micari
Gemcitabine and oxaliplatin in patients with metastatic breast cancer resistant to or pretreated with both anthracyclines and taxanes: clinical and pharmacokinetic data.
American journal of clinical oncology 2006;29(5):490-4.
2006: Luigi Cattel; Mario Airoldi; Laura Delprino; Roberto Passera; Paola Milla; Fulvia Pedani
Pharmacokinetic evaluation of gemcitabine and 2',2'-difluorodeoxycytidine-5'-triphosphate after prolonged infusion in patients affected by different solid tumors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17 Suppl 5():v142-7.
2006: Maria Laura Immordino; Franco Dosio; Luigi Cattel
Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential.
International journal of nanomedicine 2006;1(3):297-315.
2006: Luigi Cattel; Roberto Passera; Dionyssios Katsaros; Maurizio Medail; Paola Milla; Anna Maria Ferrero
Pegylated liposomal doxorubicin and vinorelbine in recurrent ovarian carcinoma: a pharmacokinetic study on alternate administration sequences.
Anticancer research 2006;26(1B):745-50.
2006: Mario Airoldi; Luigi Cattel; Roberto Passera; Fulvia Pedani; Paola Milla; Claudio Zanon
Gemcitabine and oxaliplatin in patients with pancreatic adenocarcinoma: clinical and pharmacokinetic data.
Pancreas 2006;32(1):44-50.
2005: Dionyssios Katsaros; M V Oletti; Irene A Rigault de la Longrais; A Ferrero; A Celano; Stefano Fracchioli; Michela Donadio; Roberto Passera; Luigi Cattel; Cesare Bumma
Clinical and pharmacokinetic phase II study of pegylated liposomal doxorubicin and vinorelbine in heavily pretreated recurrent ovarian carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(2):300-6.
2005: Alessandro Comandone; Roberto Passera; Antonella Boglione; Valentina Tagini; Stefano Ferrari; Luigi Cattel
High dose methotrexate in adult patients with osteosarcoma: clinical and pharmacokinetic results.
Acta oncologica (Stockholm, Sweden) 2005;44(4):406-11.
2004: Maria Laura Immordino; Paola Brusa; Flavio Rocco; Silvia Arpicco; Maurizio Ceruti; Luigi Cattel
Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs.
Journal of controlled release : official journal of the Controlled Release Society 2004;100(3):331-46.
2004: Luigi Cattel; Maurizio Ceruti; Franco Dosio
From conventional to stealth liposomes: a new Frontier in cancer chemotherapy.
Journal of chemotherapy (Florence, Italy) 2004;16 Suppl 4():94-7.
2004: Silvia Arpicco; Silvana Canevari; Maurizio Ceruti; Enrico Galmozzi; Flavio Rocco; Luigi Cattel
Synthesis, characterization and transfection activity of new saturated and unsaturated cationic lipids.
Farmaco (Società chimica italiana : 1989) 2004;59(11):869-78.
2004: Luigi Cattel; Mario Airoldi; Roberto Passera; Elga Cagliero; Barbara Stella; Franca Goffredo
Gemcitabine plus vinorelbine chemotherapy regimens: a pharmacokinetic study of alternate administration sequences.
Pharmacy world & science : PWS 2004;26(4):238-41.
2004: Luigi Cattel; Michele De Simone; Roberto Passera; Maria Cristina Verlengo; Laura Delprino
Pharmacokinetics of cisplatin in semi-closed hyperthermic peritoneal perfusion (HPP) for treatment of peritoneal carcinomatosis.
Anticancer research 2004;24(3b):2041-5.
2004: Mario Airoldi; Luigi Cattel; Giorgio Cortesina; Carlo Giordano; Fulvia Pedani; Valeria Recalenda; Marco Danova; Anna Maria Gabriele; Valentina Tagini; Camillo Porta; Cesare Bumma
Docetaxel, carboplatin and concomitant radiotherapy for unresectable squamous cell carcinoma of the head and neck: pharmacokinetic and clinical data of a phase I-II study.
American journal of clinical oncology 2004;27(2):155-63.
2003: Luigi Cattel; Giovanni La Grotta; Lucia Infante; Roberto Passera; Silvia Arpicco; Paola Brusa; Cesare Bumma
Pharmacokinetic study of oxaliplatin iv chronomodulated infusion combined with 5-fluorouracil iv continuous infusion in the treatment of advanced colorectal cancer.
Farmaco (Società chimica italiana : 1989) 2003;58(12):1333-8.
2003: Maria Laura Immordino; Paola Brusa; Silvia Arpicco; Barbara Stella; Franco Dosio; Luigi Cattel
Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel.
Journal of controlled release : official journal of the Controlled Release Society 2003;91(3):417-29.
2003: Mario Airoldi; Luigi Cattel; Sara Marchionatti; Valeria Recalenda; Fulvia Pedani; Valentina Tagini; Cesare Bumma; Fabio Beatrice; Giovanni Succo; Anna Maria Gabriele
Docetaxel and vinorelbine in recurrent head and neck cancer: pharmacokinetic and clinical results.
American journal of clinical oncology 2003;26(4):378-81.
2003: Mario Airoldi; Luigi Cattel; Giorgio Cortesina; Carlo Giordano; Roberto Passera; Fulvia Pedani; Silvia Novello; Cesare Bumma; Pietro Gabriele
Gemcitabine and vinorelbine in recurrent head and neck cancer: pharmacokinetic and clinical results.
Anticancer research 2003;23(3C):2845-52.
2003: Luigi Cattel; Maurizio Ceruti; Franco Dosio
From conventional to stealth liposomes: a new frontier in cancer chemotherapy.
Tumori 2003;89(3):237-49.
2003: Mario Airoldi; Luigi Cattel; Fulvia Pedani; Sara Marchionatti; Valentina Tagini; Cesare Bumma; Valeria Recalenda
Clinical data and pharmacokinetics of a docetaxel-vinorelbine combination in anthracycline resistant/ relapsed metastatic breast cancer.
Acta oncologica (Stockholm, Sweden) 2003;42(3):186-94.
2002: Paola Milla; Franca Viola; Simonetta Oliaro-Bosso; Flavio Rocco; Luigi Cattel; Bridget M Joubert; R J LeClair; S P T Matsuda; Gianni Balliano
Subcellular localization of oxidosqualene cyclases from Arabidopsis thaliana, Trypanosoma cruzi, and Pneumocystis carinii expressed in yeast.
Lipids 2002;37(12):1171-6.
2002: Silvia Arpicco; Franco Dosio; Andrea Bolognesi; Chiara Lubelli; Paola Brusa; Barbara Stella; Maurizio Ceruti; Luigi Cattel
Novel poly(ethylene glycol) derivatives for preparation of ribosome-inactivating protein conjugates.
Bioconjugate chemistry 2002;13(4):757-65.
2002: Stefano Alcaro; Cinzia Anna Ventura; Donatella Paolino; Danilo Battaglia; Francesco Ortuso; Luigi Cattel; Giovanni Puglisi; Massimo Fresta
Preparation, characterization, molecular modeling and in vitro activity of paclitaxel-cyclodextrin complexes.
Bioorganic & medicinal chemistry letters 2002;12(12):1637-41.
2001: Mario Airoldi; Luigi Cattel; Fulvia Pedani; Sara Marchionatti; Valentina Tagini; Cesare Bumma; Valeria Recalenda
Clinical and pharmacokinetic data of a docetaxel-epirubicin combination in metastatic breast cancer.
Breast cancer research and treatment 2001;70(3):185-95.
2001: Luigi Cattel; Valeria Recalenda; Mario Airoldi; Valentina Tagini; Silvia Arpicco; Paola Brusa; Cesare Bumma
A sequence-dependent combination of docetaxel and vinorelbine: pharmacokinetic interactions.
Farmaco (Società chimica italiana : 1989) 2001;56(10):779-84.
2001: Franco Dosio; Silvia Arpicco; Paola Brusa; Barbara Stella; Luigi Cattel
Poly(ethylene glycol)-human serum albumin-paclitaxel conjugates: preparation, characterization and pharmacokinetics.
Journal of controlled release : official journal of the Controlled Release Society 2001;76(1-2):107-17.
2001: Luigi Cattel; Valeria Recalenda; Mario Airoldi; Valentina Tagini; Laura Delprino; Flavio Rocco; Cesare Bumma
A preliminary pharmacokinetic study of docetaxel, carboplatin and concurrent radiotherapy for regionally advanced squamous cell carcinoma of the head and neck.
Farmaco (Società chimica italiana : 1989) 2001;56(9):695-9.
2001: Maurizio Ceruti; Gianni Balliano; Flavio Rocco; Paola Milla; Silvia Arpicco; Luigi Cattel; Franca Viola
Vinyl sulfide derivatives of truncated oxidosqualene as selective inhibitors of oxidosqualene and squalene-hopene cyclases.
Lipids 2001;36(6):629-36.
2001: Luigi Cattel; E Buffa; Michele De Simone; P Cesana; S Novello; Franco Dosio; Maurizio Ceruti
Melphalan monitoring during hyperthermic perfusion of isolated limb for melanoma: pharmacokinetic study and 99mTc-albumin microcolloid technique.
Anticancer research 2001;21(3C):2243-8.
2000: Barbara Stella; Silvia Arpicco; MT Peracchia; Didier Desmaële; J Hoebeke; Michel J Renoir; Jean d'Angelo; Luigi Cattel; Patrick Couvreur
Design of folic acid-conjugated nanoparticles for drug targeting.
Journal of pharmaceutical sciences 2000;89(11):1452-64.
2000: Paola Brusa; Maurizio Ceruti; R Casullo; Franco Dosio; G Squiccimarro; Giuseppe Paolo Segoloni; Luigi Cattel
Pharmacokinetic monitoring of mycophenolate mofetil in kidney transplanted patients.
Farmaco (Società chimica italiana : 1989) 2000;55(4):270-5.
2000: Franca Viola; Maurizio Ceruti; Luigi Cattel; Paola Milla; K Poralla; Gianni Balliano
Rationally designed inhibitors as tools for comparing the mechanism of squalene-hopene cyclase with oxidosqualene cyclase.
Lipids 2000;35(3):297-303.
2000: Maurizio Ceruti; P Crosasso; Paola Brusa; Silvia Arpicco; Franco Dosio; Luigi Cattel
Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing water-soluble prodrugs of paclitaxel.
Journal of controlled release : official journal of the Controlled Release Society 2000;63(1-2):141-53.
2000: P Crosasso; Maurizio Ceruti; Paola Brusa; Silvia Arpicco; Franco Dosio; Luigi Cattel
Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes.
Journal of controlled release : official journal of the Controlled Release Society 2000;63(1-2):19-30.
2000: Franca Viola; Gianni Balliano; Paola Milla; Luigi Cattel; Flavio Rocco; Maurizio Ceruti
Stereospecific syntheses of trans-vinyldioxidosqualene and 3-hydroxysulfide derivatives, as potent and time-dependent 2,3-oxidosqualene cyclase inhibitors.
Bioorganic & medicinal chemistry 2000;8(1):223-32.
1999: Maurizio Ceruti; Valentina Tagini; Valeria Recalenda; Silvia Arpicco; Luigi Cattel; Mario Airoldi; Cesare Bumma
Docetaxel in combination with epirubicin in metastatic breast cancer: pharmacokinetic interactions.
Farmaco (Società chimica italiana : 1989) 1999;54(11-12):733-9.
1999: Paola Milla; Franca Viola; Maurizio Ceruti; Flavio Rocco; Luigi Cattel; Gianni Balliano
19-Azasqualene-2,3-epoxide and its N-oxide: metabolic fate and inhibitory effect on sterol biosynthesis in Saccharomyces cerevisiae.
Lipids 1999;34(7):681-8.
1999: Giuseppe Romeo; Loredana Salerno; P Milla; Maria Angela Siracusa; Luigi Cattel; Filippo Russo
Synthesis of novel 4,5-diphenylthiazole derivatives as potential acyl-CoA:cholesterol O-acyltransferase inhibitors.
Die Pharmazie 1999;54(1):19-23.
1998: Franco Dosio; Silvia Arpicco; E Adobati; Silvana Canevari; Paola Brusa; Rita De Santis; D Parente; P Pignanelli; DR Negri; M I Colnaghi; Luigi Cattel
Role of cross-linking agents in determining the biochemical and pharmacokinetic properties of Mgr6-clavin immunotoxins.
Bioconjugate chemistry 1998;9(3):372-81.
1998: Paola Brusa; R Casullo; Franco Dosio; Luigi Cattel; S Beltramini; R Chiappetta; L Tosetti; Enzo Andorno; Mauro Salizzoni
OKT3 monitoring in the treatment of steroid-resistant acute rejection of hepatotransplant recipients.
European journal of drug metabolism and pharmacokinetics 1998;23(2):301-6.
1998: Maurizio Ceruti; Flavio Rocco; Franca Viola; Gianni Balliano; Paola Milla; Silvia Arpicco; Luigi Cattel
29-Methylidene-2,3-oxidosqualene derivatives as stereospecific mechanism-based inhibitors of liver and yeast oxidosqualene cyclase.
Journal of medicinal chemistry 1998;41(4):540-54.
1998: Luigi Cattel; Maurizio Ceruti
Inhibitors of 2,3-oxidosqualene cyclase as tools for studying the mechanism and function of the enzyme.
Critical reviews in biochemistry and molecular biology 1998;33(5):353-73.
1997: P Crosasso; Paola Brusa; Franco Dosio; Silvia Arpicco; D Pacchioni; F Schuber; Luigi Cattel
Antitumoral activity of liposomes and immunoliposomes containing 5-fluorouridine prodrugs.
Journal of pharmaceutical sciences 1997;86(7):832-9.
1997: Silvia Arpicco; Franco Dosio; Paola Brusa; P Crosasso; Luigi Cattel
New coupling reagents for the preparation of disulfide cross-linked conjugates with increased stability.
Bioconjugate chemistry 1997;8(3):327-37.
1997: Paola Brusa; Franco Dosio; S Coppo; D Pacchioni; Silvia Arpicco; P Crosasso; Luigi Cattel
In vitro and in vivo antitumor activity of immunoconjugates prepared by linking 5-fluorouridine to antiadenocarcinoma monoclonal antibody.
Farmaco (Società chimica italiana : 1989) 1997;52(2):71-81.
1996: D Parente; Giuseppe Raucci; B Celano; A Pacilli; L Zanoni; Silvana Canevari; E Adobati; MI Colnaghi; Franco Dosio; Silvia Arpicco; Luigi Cattel; Alfonso Mele; Rita De Santis
Clavin, a type-1 ribosome-inactivating protein from Aspergillus clavatus IFO 8605. cDNA isolation, heterologous expression, biochemical and biological characterization of the recombinant protein.
European journal of biochemistry / FEBS 1996;239(2):272-80.
1996: Franco Dosio; A Franceschi; Maurizio Ceruti; Paola Brusa; Luigi Cattel; M Colombatti
Enhancement of ricin toxin A chain immunotoxin activity: synthesis, ionophoretic ability, and in vitro activity of monensin derivatives.
Biochemical pharmacology 1996;52(1):157-66.
1996: Franco Dosio; Paola Brusa; P Crosasso; C Fruttero; Luigi Cattel; Andrea Bolognesi
Synthesis of different immunotoxins composed by ribosome inactivating proteins non-covalently bound to monoclonal antibody.
Farmaco (Società chimica italiana : 1989) 1996;51(7):477-82.
1995: Franca Viola; Paola Brusa; Gianni Balliano; Maurizio Ceruti; O Boutaud; Francis Schuber; Luigi Cattel
Inhibition of 2,3-oxidosqualene cyclase and sterol biosynthesis by 10- and 19-azasqualene derivatives.
Biochemical pharmacology 1995;50(6):787-96.
1995: O Boutaud; Maurizio Ceruti; Luigi Cattel; Francis Schuber
Retention of the label during the conversion of [3-3H] squalene into (3S)-2,3-oxidosqualene catalyzed by mammalian squalene oxidase.
Biochemical and biophysical research communications 1995;208(1):42-7.
1995: Luigi Cattel; Maurizio Ceruti; Gianni Balliano; Franca Viola; G Grosa; Flavio Rocco; Paola Brusa
2,3-Oxidosqualene cyclase: from azasqualenes to new site-directed inhibitors.
Lipids 1995;30(3):235-46.
1994: Gianni Balliano; Paola Milla; Maurizio Ceruti; L Carrano; Franca Viola; Paola Brusa; Luigi Cattel
Inhibition of sterol biosynthesis in Saccharomyces cerevisiae and Candida albicans by 22,23-epoxy-2-aza-2,3-dihydrosqualene and the corresponding N-oxide.
Antimicrobial agents and chemotherapy 1994;38(9):1904-8.
1994: G Grosa; Franco Dosio; Paola Brusa; Maurizio Ceruti; L Delprino; Luigi Cattel
2,3,4,5-tetrahydroxy-5-(4-hydroxyphenyl)valeric acid: a new cleavable monofunctional reagent for monoclonal antibody labeling.
Farmaco (Società chimica italiana : 1989) 1994;49(5):349-55.
1994: Paola Brusa; Franco Dosio; D Pacchioni; L Delprino; G Grosa; Gianni Bussolati; Luigi Cattel
Pharmacokinetics of an antibody-ricin conjugate administered intraperitoneally to mice.
Journal of pharmaceutical sciences 1994;83(4):514-9.
1994: Franco Dosio; Paola Brusa; L Delprino; G Grosa; Maurizio Ceruti; Luigi Cattel
A new approach in the synthesis of immunotoxins: ribosome inactivating protein noncovalently bound to monoclonal antibody.
Journal of pharmaceutical sciences 1994;83(2):206-11.
1993: Gianni Balliano; G Grosa; Paola Milla; Franca Viola; Luigi Cattel
3-Carboxy-4-nitrophenyl-dithio-1,1',2-trisnorsqualene: a site-directed inactivator of yeast oxidosqualene cyclase.
Lipids 1993;28(10):903-6.
1993: L Delprino; M Giacomotti; Franco Dosio; Paola Brusa; Maurizio Ceruti; G Grosa; Luigi Cattel
Toxin-targeted design for anticancer therapy. II: Preparation and biological comparison of different chemically linked gelonin-antibody conjugates.
Journal of pharmaceutical sciences 1993;82(7):699-704.
1993: L Delprino; M Giacomotti; Franco Dosio; Paola Brusa; Maurizio Ceruti; G Grosa; Luigi Cattel
Toxin-targeted design for anticancer therapy. I: Synthesis and biological evaluation of new thioimidate heterobifunctional reagents.
Journal of pharmaceutical sciences 1993;82(5):506-12.
1993: Gianni Balliano; Paola Milla; Maurizio Ceruti; Franca Viola; L Carrano; Luigi Cattel
Differential inhibition of fungal oxidosqualene cyclase by 6E and 6Z isomers of 2,3-epoxy-10-aza-10,11-dihydrosqualene.
FEBS letters 1993;320(3):203-6.
1993: Franco Dosio; Paola Brusa; L Delprino; Maurizio Ceruti; G Grosa; Luigi Cattel; Andrea Bolognesi; L Barbieri
A new 'solid phase' procedure to synthesize immunotoxins (antibody-ribosome inactivating protein conjugates).
Farmaco (Società chimica italiana : 1989) 1993;48(1):105-15.
1992: Maurizio Ceruti; Gianni Balliano; Franca Viola; G Grosa; Flavio Rocco; Luigi Cattel
2,3-Epoxy-10-aza-10,11-dihydrosqualene, a high-energy intermediate analogue inhibitor of 2,3-oxidosqualene cyclase.
Journal of medicinal chemistry 1992;35(16):3050-8.
1992: Gianni Balliano; Franca Viola; Maurizio Ceruti; Luigi Cattel
Characterization and partial purification of squalene-2,3-oxide cyclase from Saccharomyces cerevisiae.
Archives of biochemistry and biophysics 1992;293(1):122-9.
1992: Paola Brusa; Franco Dosio; F Pietribiasi; L Delprino; P Feraiorni; M Mariani; Gianni Bussolati; Luigi Cattel
Antitumour activity of a sterically blocked ricin immunotoxin on a human colorectal adenocarcinoma grafted subcutaneously in nude mice.
Cancer immunology, immunotherapy : CII 1992;35(6):373-80.
1991: T Cogliati; Paola Brusa; Silvana Canevari; M Caldera; Delia Mezzanzanica; Franco Dosio; Luigi Cattel; MI Colnaghi
Preparation and biological characterization of conjugates consisting of ricin and a tumor-specific non-internalizing MAb.
Anticancer research 1991;11(1):417-21.
1990: Franca Viola; Maurizio Ceruti; Gianni Balliano; Otto Caputo; Luigi Cattel
22,23-Epoxy-2-aza-2,3-dihydrosqualene derivatives: potent new inhibitors of squalene 2,3-oxide-lanosterol cyclase.
Farmaco (Società chimica italiana : 1989) 1990;45(9):965-78.
1989: Franca Viola; G Grosa; Maurizio Ceruti; Otto Caputo; Luigi Cattel
In vitro metabolism of azasqualene derivatives and their effects on aminopyrine N-demethylase activity in rat liver microsomes.
Biochemical pharmacology 1989;38(15):2497-503.
1989: Gianni Balliano; Franca Viola; Luigi Cattel
Inhibitors of ergosterol biosynthesis as potential antifungal drugs.
The Italian journal of biochemistry 1989;38(4):299A-300A.
1989: Franca Viola; Gianni Balliano; Luigi Cattel
Inhibitors of cholesterol biosynthesis as potential hypocholesterolemic drugs.
The Italian journal of biochemistry 1989;38(4):297A-299A.
1989: Luigi Cattel; Maurizio Ceruti; Gianni Balliano; Franca Viola; G Grosa; Francis Schuber
Drug design based on biosynthetic studies: synthesis, biological activity, and kinetics of new inhibitors of 2,3-oxidosqualene cyclase and squalene epoxidase.
Steroids 1989;53(3-5):363-91.
1989: Paola Brusa; F Pietribiasi; Gianni Bussolati; Franco Dosio; R Arione; paolo comoglio; M Prat; Luigi Cattel
Blocked and not blocked whole-ricin-antibody immunotoxins: intraperitoneal therapy of human tumour xenografted in nude mice.
Cancer immunology, immunotherapy : CII 1989;29(3):185-92.
1988: Gianni Balliano; Franca Viola; Maurizio Ceruti; Luigi Cattel
Inhibition of sterol biosynthesis in Saccharomyces cerevisiae by N,N-diethylazasqualene and derivatives.
Biochimica et biophysica acta 1988;959(1):9-19.
1988: Luigi Cattel; L Delprino; Paola Brusa; Franco Dosio; paolo comoglio; M Prat
Comparison of blocked and non-blocked ricin-antibody immunotoxins against human gastric carcinoma and colorectal adenocarcinoma cell lines.
Cancer immunology, immunotherapy : CII 1988;27(3):233-40.
1986: N Gerst; Francis Schuber; Franca Viola; Luigi Cattel
Inhibition of cholesterol biosynthesis in 3T3 fibroblasts by 2-aza-2,3-dihydrosqualene, a rationally designed 2,3-oxidosqualene cyclase inhibitor.
Biochemical pharmacology 1986;35(23):4243-50.
1986: Luigi Cattel; Maurizio Ceruti; Franca Viola; L Delprino; Gianni Balliano; A Duriatti; P Bouvier-Navé
The squalene-2,3-epoxide cyclase as a model for the development of new drugs.
Lipids 1986;21(1):31-8.
1985: A Duriatti; P Bouvier-Nave; Pierre Benveniste; Francis Schuber; L Delprino; Gianni Balliano; Luigi Cattel
In vitro inhibition of animal and higher plants 2,3-oxidosqualene-sterol cyclases by 2-aza-2,3-dihydrosqualene and derivatives, and by other ammonium-containing molecules.
Biochemical pharmacology 1985;34(15):2765-77.
1983: Franca Viola; Otto Caputo; Gianni Balliano; L Delprino; Luigi Cattel
Side chain degradation and microbial reduction of different steroids by Aspergillus auroefulgens.
Journal of steroid biochemistry 1983;19(4):1451-8.
1983: Alain Rahier; P Bouvier; Luigi Cattel; A Narula; Pierre Benveniste
Inhibition of 2,3-oxidosqualene: beta-amyrin-cyclase, S-adenosyl-L-methionine: cycloartenol C-24-methyltransferase and cycloeucalenol: obtusifoliol isomerase by rationally designed molecules containing a tertiary amine function.
Biochemical Society transactions 1983;11(5):537-43.